Research leads to brain cancer clinical trial
Researchers used tumour cells derived from 100 different glioblastoma patients to test drugs that could target the disease. …
Researchers used tumour cells derived from 100 different glioblastoma patients to test drugs that could target the disease. …
source : http://www.sciencedaily.com/releases/2014/05/140528102927.htm
source : http://www.sciencedaily.com/releases/2014/04/140404221744.htm
In this study, researchers assessed the outcomes of 280 prostate cancer (Cap) patients, and reviewed the DNA "fingerprints" of each patient’s tumor (using the patient’s initial diagnostic core biopsy) to determine if gene copy number alterations (CNAs), or breaks in CFSs, were related to a less positive response to treatment. Two groups were analyzed: 126 localized intermediate risk CaP patients who had received image-guided radiation therapy (IGRT) treatments, with a mean dose of 74.6 Gy; and 154 localized intermediate and high risk CaP patients who had undergone radical prostatectomy (RP), which is the surgical removal of the entire prostate gland. Utilizing an array comparative genomic hybridization (aCGH), DNA from frozen needle biopsies of the RT patients was analyzed for 13 previously characterized CFSs: FRA2G, FRA3B, FRA4F, FRA6E, FRA6F, FRA7E, FRA7G, FRA7H, FRA7I, FRA7K, FRA8C, FRA9E, FRA16D. …
source : http://www.foxnews.com/health/2013/06/25/woman-drinks-only-soda-for-16-years-suffers-heart-problems/